Intravesical Therapy

DALLAS, May 15, 2026 CG Oncology announced positive initial Phase 2 data from the CORE-008 Cohort CX trial, evaluating...

SUZHOU, China, February 26, 2026 ImmVira Group announced encouraging preliminary clinical data for its oncolytic virus candidate MVR-T3011 in...